Patients with moderate to severe Hidradenitis Suppurativa, chronic skin condition featuring lumps in places such as the armpits or groin, will be enrolled to evaluate new treatments for this skin condition. Clinical trial participants will be monitored closely by medical professionals for the duration of the study. The goal of this Hidradenitis Suppurativa clinical trial is to develop better understanding of Hidradenitis Suppurativa and develop safe and effective therapies.
Up to 136 weeks depending on study
Subject compensation and travel assistance may be available. Study medication, study related exams, and lab tests will be provided at no cost.
For general questions regarding our clinical trials, please contact our team at firstname.lastname@example.org or fill out the contact form below.
A clinical trial is a research study conducted with human volunteers to test the effectiveness and safety of new drugs, devices, or interventions. Our Clearlyderm clinical trials focus on skin conditions such as psoriasis, acne, rosacea, or atopic dermatitis (eczema).
To enroll in one of our clinical trials, contact our office. You will need to review and complete informed consent documents and complete screening procedures prior to participation.
Like any medical treatment, potential risks exist. However, participants are informed of these risks prior to starting the clinical trials and receive monitoring and follow-up care throughout the trial duration if selected to participate.
Hidradenitis Suppurativa is a chronic skin condition that leads to painful lumps and skin abscesses that usually occur around hair follicles. While the exact cause of HS is unknown, it is believed to be caused by a combination of genetic, environmental, and hormonal factors.
You can contact the Clearlyderm team at email@example.com with any questions you may have about our clinical trials or fill out the form above.